News and Reports
-
Viela Bio Closes $75 Million Series B Financing
17 June 2019Download -
Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab
13 June 2019Download -
SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for the Treatment of a Severe Form of Neurofibromatosis Type 1
3 June 2019Download -
Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor
24 April 2019Download -
Arrakis Therapeutics Raises $75M Series B To Develop Small-Molecule Medicines Targeting RNA
18 April 2019Download -
HOOKIPA Pharma Announces Pricing of Initial Public Offering
17 April 2019Download -
SpringWorks Therapeutics Completes $125 Million Series B Financing
1 April 2019Download -
iTeos Therapeutics Announces Eight Data Presentations for A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Annual Meeting 2019
29 March 2019Download -
HOOKIPA PROPOSES IPO AS ITS CANCER VACCINES HEAD TOWARDS THE CLINIC
22 March 2019Download -
Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II
21 March 2019Download -
Forbius Announces the First Patient Dosed in a Phase 1b Diffuse Cutaneous Systemic Sclerosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor
4 March 2019Download -
Principia Biopharma Announces Positive Data from Phase 2 Pemphigus Vulgaris Trial at 2019 American Academy of Dermatology Annual Meeting in Late-Breaking Presentation
2 March 2019Download -
HOOKIPA Pharma Raises $37.4 million (?33.2 million) in Series D Financing
26 February 2019Download -
Forbius Announces a Clinical Trial Collaboration with the Myeloproliferative Neoplasm Research Consortium to Evaluate AVID200 a Novel TGF beta Inhibitor in Myelofibrosis
14 February 2019Download -
Harmony Biosciences announces file acceptance of its new drug application for pitolisant
12 February 2019Download -
Adrenomed AG Announces Publication of Phase II Trial Design of Adrecizumab to Treat Sseptic Shock
7 February 2019Download -
Gynesonics raises $75 million to commercialize uterine fibroid therapy
3 January 2019Download -
Amicus SA of Switzerland announced today that it had signed 15 deals for new territories and / or products in the course of 2018
2 January 2019Download -
Cathay Industrial Biotech invests an additional USD 500 million to expand its production capacity for new bio-based materials
8 December 2018Download -
Adrenomed closes € 24 M financing led by Wellington and HBM
26 November 2018Download -
TP Therapeutics Raises $80 Million for Targeted Cancer Therapies
19 October 2018Download -
Principia Achieves $10 Million in Additional Milestones Related to Development of PRN2246/SAR442168
16 October 2018Download -
Sphingotec Raises €20 Million from HBM and Wellington Partners
8 October 2018Download -
Paratek Announces FDA Approval of NUZYRA TM (Omadacycline)
2 October 2018Download -
FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
2 October 2018Download